Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natoli

Showing results (781-790 of 1,181) with videos related to

Pageof 119
Sort By:
The EMBO Journal|December 24, 2004
Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expressionMarcela Covic, Paul O Hassa, Simona Saccani, et al.
Inorganic Chemistry|July 24, 2015
Synthesis and Electronic Structure of Ru2(Xap)4(Y-gem-DEE) Type Compounds: Effect of Cross-ConjugationWilliam P Forrest, Mohommad M R Choudhuri, Stefan M Kilyanek, et al.
Critical Reviews in Oncology/Hematology|November 9, 2016
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, et al.
Gut|May 14, 2022
Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cellsGabriele Alfarano, Matteo Audano, Pierluigi Di Chiaro, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|September 30, 2024
Effects of submersion on VO<sub>2</sub>: comparing maximum aerobic exertion on land and underwaterNicholas C Bartlett, Matthew S Makowski, Mary C Ellis, et al.
Cancer Immunology, Immunotherapy : CII|April 12, 2011
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu miceRonald P Gladue, Timothy Paradis, Susan H Cole, et al.
Microorganisms|September 28, 2021
Novel Approach to Dental Biofilm Management through Guided Biofilm Therapy (GBT): A ReviewDeepti Shrivastava, Valentino Natoli, Kumar Chandan Srivastava, et al.
Journal of Translational Autoimmunity|February 3, 2025
Across ancestries, HLA-B∗08:01∼DRB1∗03:01 (DR3) and HLA-DQA∗01:02 (DR2) increase the risk to develop juvenile-onset systemic lupus erythematosus through low complement C4 levelsYves Renaudineau, Amandine Charras, Valentina Natoli, et al.
Journal of Molecular Biology|September 12, 2013
Switching between the alternative structures and functions of a 2-Cys peroxiredoxin, by site-directed mutagenesisF Angelucci, F Saccoccia, M Ardini, et al.
International Journal of Cancer|October 24, 2008
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapiesNicola Tinari, Rossano Lattanzio, Patrizia Querzoli, et al.
Pageof 119

Showing results (781-790 of 1,181) with videos related to

Sort By:
Pageof 119
The EMBO Journal|December 24, 2004
Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expressionMarcela Covic, Paul O Hassa, Simona Saccani, et al.
Inorganic Chemistry|July 24, 2015
Synthesis and Electronic Structure of Ru2(Xap)4(Y-gem-DEE) Type Compounds: Effect of Cross-ConjugationWilliam P Forrest, Mohommad M R Choudhuri, Stefan M Kilyanek, et al.
Critical Reviews in Oncology/Hematology|November 9, 2016
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, et al.
Gut|May 14, 2022
Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cellsGabriele Alfarano, Matteo Audano, Pierluigi Di Chiaro, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|September 30, 2024
Effects of submersion on VO<sub>2</sub>: comparing maximum aerobic exertion on land and underwaterNicholas C Bartlett, Matthew S Makowski, Mary C Ellis, et al.
Cancer Immunology, Immunotherapy : CII|April 12, 2011
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu miceRonald P Gladue, Timothy Paradis, Susan H Cole, et al.
Microorganisms|September 28, 2021
Novel Approach to Dental Biofilm Management through Guided Biofilm Therapy (GBT): A ReviewDeepti Shrivastava, Valentino Natoli, Kumar Chandan Srivastava, et al.
Journal of Translational Autoimmunity|February 3, 2025
Across ancestries, HLA-B∗08:01∼DRB1∗03:01 (DR3) and HLA-DQA∗01:02 (DR2) increase the risk to develop juvenile-onset systemic lupus erythematosus through low complement C4 levelsYves Renaudineau, Amandine Charras, Valentina Natoli, et al.
Journal of Molecular Biology|September 12, 2013
Switching between the alternative structures and functions of a 2-Cys peroxiredoxin, by site-directed mutagenesisF Angelucci, F Saccoccia, M Ardini, et al.
International Journal of Cancer|October 24, 2008
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapiesNicola Tinari, Rossano Lattanzio, Patrizia Querzoli, et al.
Pageof 119